Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4784426
Max Phase: Preclinical
Molecular Formula: C40H52N4O11
Molecular Weight: 764.87
Molecule Type: Unknown
Associated Items:
ID: ALA4784426
Max Phase: Preclinical
Molecular Formula: C40H52N4O11
Molecular Weight: 764.87
Molecule Type: Unknown
Associated Items:
Canonical SMILES: NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](COCc4ccc5ccccc5c4)[C@@H](OCc4ccc5ccccc5c4)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O
Standard InChI: InChI=1S/C40H52N4O11/c41-16-28-31(45)33(47)34(48)40(52-28)55-37-27(43)15-26(42)36(35(37)49)54-39-32(46)30(44)38(51-18-21-10-12-23-6-2-4-8-25(23)14-21)29(53-39)19-50-17-20-9-11-22-5-1-3-7-24(22)13-20/h1-14,26-40,45-49H,15-19,41-44H2/t26-,27+,28-,29-,30-,31-,32-,33+,34-,35-,36+,37-,38-,39-,40-/m1/s1
Standard InChI Key: YKZIBGJSRWVSSS-YCSFWMHWSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 764.87 | Molecular Weight (Monoisotopic): 764.3633 | AlogP: -0.54 | #Rotatable Bonds: 12 |
Polar Surface Area: 260.61 | Molecular Species: BASE | HBA: 15 | HBD: 9 |
#RO5 Violations: 3 | HBA (Lipinski): 15 | HBD (Lipinski): 13 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 12.07 | CX Basic pKa: 9.50 | CX LogP: -0.35 | CX LogD: -5.67 |
Aromatic Rings: 4 | Heavy Atoms: 55 | QED Weighted: 0.09 | Np Likeness Score: 0.78 |
1. Subedi YP,Kjellgren A,Roberts P,Montgomery H,Thackeray N,Fiori MC,Altenberg GA,Chang CT. (2020) Amphiphilic aminoglycosides with increased selectivity for inhibition of connexin 43 (Cx43) hemichannels., 203 [PMID:32679454] [10.1016/j.ejmech.2020.112602] |
Source(1):